Starling Oncology, Inc. (STLN)

6.70 -0.22 (-3.18%) USD  |  NASDAQ  |  Oct 13, 16:00
6.75 +0.05 (+0.75%) Pre-Market: 08:33
More

Starling Oncology EPS Estimates for 2 Fiscal Years Ahead

EPS Estimates for 2 Fiscal Years Ahead Chart

View EPS Estimates for 2 Fiscal Years Ahead for STLN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS Estimates for 2 Fiscal Years Ahead Data

View and export this data back to 2022. Start Trial.
Date Value
November 09, 2023 --
November 10, 2022 --
Date Value
September 28, 2022 --
September 14, 2022 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for 2 Fiscal Years Ahead Range, Past 5 Years

View EPS Estimates for 2 Fiscal Years Ahead Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for 2 Fiscal Years Ahead Benchmarks

View EPS Estimates for 2 Fiscal Years Ahead Benchmarks
Start Trial
Astrana Health, Inc. Upgrade
Agilon Health, Inc. Upgrade
Nakamoto, Inc. Upgrade
American Oncology Network, Inc. --
Sonida Senior Living, Inc. Upgrade